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INTRODUCTION 
Diabetic retinopathy is one of the leading cause of blindness across the 
globe. Clinical and experimental research has shown that choroid may have 
a role in the pathology of Diabetic retinopathy.  
 
Choroid is an important vascular tissue that supplies blood to RPE and 
photoreceptors1. Many vascular studies like ICG2 as well as 
histopathological studies3 have shown increased tortuosity, focal vascular 
dilatation in diabetic retinopathy. 
 
Until recently, the choroid’s inaccessibility essentially buried beneath the 
retina has made it a little understood anatomical structure. Today, we’re able 
to image deeper into the eye than ever before, allowing us the opportunity to 
evaluate choroidal thickness and morphology both for the benefit of patient 
treatment and for a better understanding of  diabetic retinopathy and other 
retinal diseases4. The technology making this possible is enhanced depth 
choroidal imaging, a function of optical coherence tomography. 
 
With the spectralis OCT imaging of choroid is now possible. Studies 
have been done in caucasian and oriental population to assess choroidal 
thickness in diabetic Retinopathy .Studies have proven significant 
correlation with severity of diabetic Retinopathy. 
 
 
Our study focuses on the assessment of subfoveal choroidal thickness in 
various stages of DR. 
  
 
 
DIABETES 
DIABETES MELLITUS: 
Diabetes mellitus is the most common endocrine disease in adulthood 
which results from diminished secretion of insulin by BETA cells of islet of 
Langerhans. 
PREVALANCE: 
High percentage of patients belong to the non-insulin-dependent 
diabetes mellitus (NIDDM) or type 2 diabetes. Type 1 DM accounts for 
15%of the diabetic population. Prevalence of Diabetic retinopathy according 
Wisconsin Epidemiological Study of Diabetic Retinopathy (WESDR) was 
50.1%5 .The incidence was 54.2% in the diabetes control and complications 
trial (DCCT)6 in IDDM .The incidence was 35-39% in United Kingdom 
Prospective Diabetes Study (UKPDS)7 in NIDDM. 
In two studies8-9 from South Indian population, the prevalence rates of 
Diabetic retinopathy in Non Insulin Dependent Diabetes Mellitus patients 
were 34.1% and 37%.  According to the WHO, India has 62 million diabetic 
subjects at present as per the World Health Organization (WHO) estimates. 
In the Andhra Pradesh Eye Disease Study (APEDS)10, it was reported that 
the incidence of DR was 22.4%.  The Chennai Urban Rural Epidemiology 
 
 
Study (CURES)11, reported the  incidence of DR to be 18% in an urban 
diabetic population  
TYPES: 
Patients with DM can be divided into two groups: 
Ø Type 1 :Insulin dependent 
Ø Type 2 :Non insulin dependent 
Effect of hyperglycemia: 
Ø Diabetic neuropathy 
Ø Diabetic nephropathy 
Ø Diabetic retinopathy 
Effect of hyperglycemia on ocular tissues:10 
Ø Diabetic retinopathy 
Ø Diabetic papillopathy 
Ø Dry eye syndrome 
Ø Keratopathy 
 
 
 
 
 
 
DIABETIC RETINOPATHY 
Risk Factors: 
General: 
1. Duration of diabetes13 
2. Metabolic control 
Systemic Factors: 
1. Nephropathy 
2. Systemic hypertension 
3. Pregnancy 
4. Hyperlipidemia 
5. obesity 
6. Anemia 
Pathogenesis of Diabetic retinopathy: 
The triggering factor for DR is hyperglycemia. Cells which are not 
capable of bringing down the transport of glucose inside the cell in presence 
of increased blood glucose levels like the endothelial cells of the retinal 
capillaries are selectively damaged in Diabetes. 
 
 
 
 
Sorbitol Pathway: 
Excess glucose 
 
Sorbitol 
 
Accumulation of water by sorbitol 
 
Pericyte Loss, decreased Photoreceptor function, decreased retinal 
blood flow and vasodilatation. 
 
FIG 1.  SORBITOL PATHWAY 
Aldose reductase 
 
 
Advanced glycation end products: 
Adhesion of glucose with proteins 
 
Cross linking and AGE production 
 
FIG  2. ADVANCED GLYCATION END PRODUCTS 
Protein Kinase C pathway: 
Incomplete glucose metabolism 
 
Accumulation of Diacylglycerol 
 
Increased activity of Protein kinase C 
 
Decreases retinal blood flow and blood retinal barrier breakdown 
 
 
 
FIG 3. EFFECTS OF PKC 
Free radicals: 
Accumulated glucose and AGE products undergo auto oxidation 
resulting in free radical release. AGE inactivates anti-oxidant enzymes 
which remove excess free radicals. 
Angiogenic factors: 
Hypoxia 
 
Release of vasoendothelial growth factors by 
RPE, Macrophages and T-cells 
 
Breakdown of Blood retinal barrier and neovascularisation in retina 
 
 
 
FIG 4. ANGIOGENIC FACTORS 
Consequences of Diabetes in retina: 
1. Microaneuryms –Leading to leakage 
2. Retinal ooedema 
3. Hypoxia: 
It causes stimulation of: 
1. Vasoendothelial growth factors which causes growth of new vessels. 
2. Arterio-venous shunts – Intraretinal microvascular abnormalities. 
 
 
 
 
 
Causes of vision loss in Diabetic retinopathy: 
1. Macular ischemia 
2. Macular oedema 
3. Tractional Retinal detachment 
4. Vitreous heammorhage 
5. Neovascular glaucoma. 
Classification of Diabetic retinopathy  
 It is classified on the basis of Early Treatment Diabetic Retinopathy 
Study.14 
Early treatment Diabetic retinopathy study  
Non –proliferative DR:  
Very Mild: 
Microaneurysms only  
Mild: 
      Any or all of : microaneurysms, retinal haemorrhages, exudates, cotton 
wool spots, upto the level of moderate NPDR .No IRMA or significant 
beading. 
 
 
 
 
FIG 5.)  MILD NPDR 
Moderate NPDR: 
Severe retinal haemorrhages ( more than ETDRS standard photograph 
2A:about 20 medium – large per quadrant) in 1-3 quadrants or mild 
intraretinal microvascular abnormalities. 
Significant venous beading can be present in no more than 1 
quadrant. 
Cotton wool spots commonly present. 
 
 
 
FIG 6 MODERATE NPDR 
 Severe NPDR: 
4-2-1  rule:  (One or more of following) 
Severe haemorrhages in all 4 quadrants. 
Significant venous beading in 2 or more quadrants. 
Moderate IRMA in 1 or more quadrant. 
 
 
 
 
 
FIG 7. SEVERE NPDR 
Very Severe NPDR: 
Two or more of the criteria for severe. 
Proliferative Diabetic retinopathy:  
Mild-Moderate: 
New vessels on the disc NVD or new vessels elsewhere (NVE) ,but 
extent insufficient to meet high risk criteria.  
 
 
 
High-Risk PDR: 
New vessels on the disc (NVD) greater than ETDRS standard 
photograph 10 A(1/3 disc area). 
Any NVD with vitreous or pre retinal haemorrhage. 
NVE greater than ½ disc area with vitreous or pre retinal 
haemorrhage (or haemorrhage with presumed obscured NVD/NVE) 
Advanced Diabetic Eye disease: 
1. Persistent Vitreous haemorrhage 
2. Neovascular Glaucoma.  
3. Tractional Retinal detachment  
 
FIG 8.  PDR 
 
 
Diabetic Macular oedema: 
It is the most common cause of visual impairment. The leaked fluid 
from the microaneurysms is initially collected between the outer plexiform 
and inner nuclear layers.Later it may involve the inner plexiform and nerve 
fibre layers. 
Focal Maculopathy: 
Caused by focal leakage from microaneurysms.Incomplete or 
complete ring of hard exudates may be present 
Diffuse Maculopathy: 
Due to generalized leakage from capillaries. 
Ischemic maculopathy: 
Characterised clinically by presence of reduced visual acuity in 
association with relatively normal appearance of macula although 
haemorrhage and exudates may be present elsewhere. 
  
 
 
Clinically significant Macular oedema: 
 
FIG 9 CSME 
Was defined in ETDRS as: 
“ Hard exudates at or within 500 micrometers from the centre of the 
macula with adjacent retinal thickening 
Retinal thickening at or within 500 micrometersfrom the centre of the 
macula. 
Retinal thickening of 1500 micrometers or more, any part of which is 
within one disc diameter of the centre of macula”. 
 
 
 
CHOROID 
 
FIG 11. CH –CHOROID; RPE –RETINAL PIGMENT EPITHELIUM, 
R-RETINA 
Development: 
         Choroid develops from the neural crest cells15,16,17. The choroidal 
stroma develops from the neural crest cells which condense and differentiate 
into it (Ensheated choroidal stroma).The embryonic annular vessels are 
formed by the mesenchymal tissue which is invaded early by the 
endothelium lined blood spaces. The choriocapillaris differentiate during the 
fourth week of gestation.  
         The fenestrations which are the characteristic feature of the 
choriocapillaris develop after the seventh week of gestation. This 
 
 
development takes place alongside the thinning of endothelium, 
enlargement of the vessel lumen, increase in the number of intracellular 
vesicles.  Basal lamina also becomes well defined, continuous and thicker. 
       The endothelium of the choriocapillaris is the last to be organised. 
      At the end of the second month certain stuctures can be distinguished 
better like: 
1. Branches of short posterior ciliary arteries  
2. Rudimentary vortex veins.. 
Timeline for development of layers of choroid: 
First and second month: Capillaries 
Third month: Haller layer and choriocapillaris (bruch’s membrane derives 
from the choriocapillaris) 
Fifth month: Sattler layer. 
 
FIG 12. LAYERS OF CHOROID: 
 
 
Anatomy: 
Choroid is an soft, pigmented, extremely vascular tissue present 
between the retina and the sclera. 
Anteriorly it extends from the optic nerve to the oraserrata. The 
smooth inner surface is firmly attached to the sclera in both the region of the 
optic nerve and also aroundthe area where the vortex veins exit the eyeball.  
   The long and short posterior ciliary arteries and present in the 
suprachoroidal lamina which is a pigmented sheet lying between the choroid 
and the sclera.  
Layers of choroid: 
It can be divided into  
1. Bruch’s membrane 
2. Choriocapillaris 
3.  Sattler’s layer 
4. Haller’s layer 
Bruch’s Membrane: 
     The bruch’s membrane is a thin noncellular multi-layered structure  
extending fromoraserrata to the optic disc. It lies between the 
choriocapillaris and the RPE. It consists of five layers: 
 
 
1. The inner basal lamina lies is in continuity with the basal lamina of 
ciliary epithelium. Retinal pigment epithelium is separated  by a 100 
micrometre wide zone. 
2. Interweaving collagen fibres forms the inner collagenous zone .It is 1 
micrometers in thickness 
3. Elastic zone is composed of  dense cortex and a homogenous core of 
interwoven band of elastic fibres. 
4. The outer collagenous zone is structurally similar to the inner zone. 
5. A non-continious sheet across bruch’s membrane is formed by the 
Basement membrane of choriocapillaris. 
 
Fig13 ) Layers of choroidal vasculature A: Histological section (H/E). B: 
Three-dimensional scheme 1: Sclera; 2: Suprachoroid; 3: Haller´s 
Layer; 4: Medium-sized vessel layer Sattler´s Layer;                                
5: Choriocapillaries; 6: Bruch´s membrane; 7: Retinal pigment 
epithelium 
 
 
Choriocapillaris: 
The choriocapillaris is formed by a lobular organization of wide 
lumen capillaries.It supplies an independent segment of choriocapillaris. It 
lies in a single plane. 
The lobular network is well developed at the posterior pole. It is less 
regular at the ora serrata anteriorly.  
8 – 16 precapillary arterioles feeds the submacular choroid where 
marked interateriolar anastomosis is present. 
              Studies have shown that the lobular anatomy is venocentric. Here, 
the draining venules are present more centrally whereas the feeding 
arterioles are situated at the periphery. Occlusive events in the choroid and 
at the optic nerve are due to the presence of vascular watershed zones which 
are created by the lobules which are arranged in a mosaic pattern with very 
little anastomosis between them.  
           The vessel walls are extremely thin and contain multiple 
fenestrations, especially on the surface facing the retina .They show 
junctions of the zonula adherens type, so zonula occludens is not well 
developed as in the retinal capillaries. Pericytes are located along the outer 
wall. As a result, small molecules such as fluorescein, which diffuse across 
 
 
the endothelium of the choriocapillaris, do not leak through medium and 
large choroidal vessels. 
 
FIG 14 : SHOWING LAYERS OF CHOROID: OUTER ARTERIES AND VEINS 
(RED /BLUE ARROW), MEDIAL ARTERIOLE AND VEIN (RED ARROW), 
INNER CAPILLARY BED (STAR) 
 
 
 
 
Haller’s and Sattler’s layer: 
The middle and outer choroidal vessels are not fenestrated. The large 
vessels typical of small arteries elsewhere, possess an internal elastic lamina 
and smooth muscle cells in the media. As a result, small molecules such as 
fluorescein, which diffuse across the endothelium of the choriocapillaris, do 
not leak through medium and large choroidal vessels. 
  Abundant melanocytes as well as occasional macrophages, 
lymphocytes, mast cells, and plasma cells appear throughout the choroidal 
stroma. The intercellular space contains collagen fibers and nerve fibers. 
The degree of pigmentation observed ophthalmoscopically in the ocular 
fundus primarily depends on the number of pigmented melanocytes in the 
choroid. Melanosomes are absent from the RPE and choroid of albinos. 
The degree of pigmentation in the choroid must be considered when 
one is performing photocoagulation, because it influences the absorption of 
laser energy. 
Thickness of Choroid: 
The thickness of choroid was found to be  100 -200 micrometres. The 
thickness was greatest belowthe macula (500 -1000 micrometres).  
 
 
Spaide et al4 noted that choroid was thickest in the subfoveal region 
and was reported thinner nasally than temporally. 
Blood Supply: 
The long and short posterior ciliary arteries along with the perforating 
anterior ciliary arteries supply the choroid. Venous drainage is through the 
vortex system. The blood flow in choroid is higher than other tissues in the 
human body.      
As a result, the oxygen content of choroidal venous blood is only 2%-
3% less than that of arterial blood. 
The close proximity of the choroidal watershed zones to the 
peripapillary region and the macula may prove the possible role of choroidal 
blood flow in ischemic optic neuropathies and in macular ischemic lesions. 
Choroidal watershed zones: 
The border between the areas of distribution of any two end- arteries 
in a tissue is called a ‘water-shed’ zone. All choroidal arteries are end 
arteries. The choroidal vasculature has several such watershed zones, which 
are arranged as follows: 
Ø Between Posterior ciliary arteries (PCA)  
Ø Between short PCA 
 
 
Ø Between the short and long PCAs 
Ø Between the PCAs and the anterior ciliary arteries 
Ø Between the choriocapillaris lobules 
Ø Between the vortex veins 
   The close proximity of the choroidal watershed zones to the peripapillary 
region and the macula may prove the possible role of choroidal blood flow 
in ischemic optic neuropathies and in macular ischemic lesions. 
 
FIG 15. WATERSHED ZONES 
Functions of choroid:18 
1. Supplying oxygen and nutrients to RPE and photoreceptors 
2. Thermoregulation via heat dissipation 
 
 
3. Light absorption 
4. Controls IOP through the vasomotor control of blood flow 
5. Drainage of aqueous humor through the uveoscleral pathway. 
Autoregulation: 
It is a process within many biological systems wherein an internal 
mechanism which is adaptive in nature works to mitigate or adjust the 
biological systems response to stimuli. It is most commonly present in the 
kidney, heart and brain and most systems of the body have some amount of 
autoregulation. 
In human choroids, varying degrees of autoregulation have been 
found. Decrease in perfusion pressure may be induced by changes in blood 
flow which is elicited by step increases in intraocular pressure 
(IOP)19.Isometric exercise also brings about an increase in the perfusion 
pressure20.But these changes in blood flow were not linearly related to the 
changes in perfusion pressure, indicating presence of some degree of 
autoregulation. Studies21 have noted that there was an increase in choroidal 
blood flow by approximately 1.5% /mm Hg PCO2 when there was increase 
in the levels of arterial CO2 tension. 
  
 
 
DIABETIC CHOROIDOPATHY 
The main characteristic finding in diabetic microangiopathy is the 
thickening of basement membrane in capillaries of all organs including 
choroid 22-26. In addition to these changes the other findings in the choroid 
are: 
Histopathalogical changes: 
Hidyat et al3 in his study noted that there was presence of:  
1. Obstruction of choriocapillaris 
2. Choroidal aneurysms 
3. Choroidal neovascularisation 
4. Loss of viable endothelial cells 
5. Degeneration of choriocapillaris. 
Indocyanine green Angiography: 
Weinberger et al2 in his study found that there was presence of 
1.) Hypoflourescent spots: 
a. Due to ischemic changes of choroid  
b. Defect of choriocapillaris 
 
 
 
2.)Hyperflourescent spots: 
a. Due to choroidal neovascularisation leading to leakage. 
b. Due to presence of intra –choroidal microvascular abnormalities. 
Laser Doppler flowmetrey: 
Nagoka et al27reduction in blood volume in sub foveal area in non 
proliferative diabetic retinopathy and more markedly in Proliferative 
diabetic retinopathy. 
  
 
 
FACTORS AFFECTING CHOROIDAL THICKNESS 
Within choroid: 
Tonicity of Choroid: 
Changing the tonicity of the choroid is one of the likely mechanisms 
by which choroidal expansion can take place. Wallman et al28has shown that 
the eyes which are recovering from deprivation-induced myopia synthesize 
markedly higher amounts of proteoglycans than choroids from normal eyes 
leading to rapid increase in choroidal thickening. 
Movement of fluid from RPE: 
 In studies29, it was found that  movement of ions and fluids from the 
RPE and outer retina into the choroid via the RPE pump could cause an 
increase in choroidal thickness if the movement of solutes from the 
choriocapillaris from the choroid into retina do not match the same.  
Changes in Vascular permeability: 
Increase in capillary permeability results in an increased movement of 
fluid from choroidal vessels which in turn has an effect on the choroidal 
thickness .This movement causes the proteins to move into extracellular 
matrix and followed by passive fluid flow 30-32. 
 
 
           They also found that protein content in suprachoroidal fluid is 
decreased in thinned choroids (deprivation myopia) and is more in thicker 
choroids. The reason being in all deprivation induced myopia the protein 
content was more , thus making the choroid thinner and the protein content 
was less in recovering eyes making the choroid thicker. 
Movement of fluid from Anterior chamber to choroid:  
Another factor which can affect the choroidal thickness is movement 
of aqueous from the anterior chamber through the ciliary muscleinto the 
choroid. This movement of aqueous into the choroid increases the size of 
the lacunae thereby affecting its thickness. 
Wallman et al28 found that choroidal lacunae and anterior chamber 
were connected by injection of horseradish peroxidase into the anterior 
chamber. Tracer molecules were found four hours later in the lacunae of 
suprachoroid.Pendark et al 33 also found presence of fluorescein Dextran in 
suprachoroidal space after injecting it into anterior chamber. 
Systemic: 
Diabetes: 
Histological examinations have proved that there is presence of 
increased tortuosity of the blood vessels, focal vascular dilatation , 
 
 
narrowing of vessels with hypercellularity and vascular loops and 
microaneurysm formation.3 
In previous studies investigations have reported selective filling of 
choriocapillaris in indocyanine angiography 2 and a reduction of blood flow 
in Doppler studies27.The decrease in blood flow was postulated to be 
secondary to retinal hypoxia. 
Adhi et al34 showed that  due to closure of choriocappillaris in 
diabetic eyes there is an reduction in the choroidal vessel layer as well as the 
thickness of the choriocapillaris. Regatieri et al35 proposed that since the 
choroid was the major source of nutrition for the RPE, the reduction in 
choroidal thickness was due to the hypoxia of retinal tissue. 
Hypercholestremia: 
Salazar et al36 has shown that hypercholestremia produces 
atherosclerotic changes of the choroid which leads to increase in thickness 
in animal models. He also stated that there is no reversal of the thickening 
once there is normalisation of cholesterol levels. 
Salazar et al36 also proved that there is hypertrophy of the endothelial 
and vascular smooth muscle cells and also a buildup of lipids at the 
suprachoroid. 
 
 
Wong et al37 noted that the subfoveal choroid was thicker in patients 
with hypercholestremia 
Blood pressure: 
Maul et al38 found that there was a correlation between increased 
diastolic blood pressure and choroidal thickness. He stated that increased 
diastolic blood pressure may cause increased choroidal blood flow which 
caused an increase in choroidal thickness. Reiner et al 39 in his study noted 
that as the blood pressure declined there was a notable decrease in the 
choroidal blood flow. 
General factors: 
Age: 
          Choroidal thickness decreases with age. This is because there is a 
reduction in the number increase in choroidal blood calibre of vessels thus 
contributing to the decrease in thickness.16 
Spaide et al4 in his study showed that there is a decrease in choroidal 
thickness by 15.6 micrometers with each decade of life. This negative 
correlation of choroidal thickness with age may play a role in the 
pathogenesis of age related eye diseases. 
  
 
 
Diurnal variation: 
        Studies have proved there is significant diurnal variation in choroidal 
thickness. 
In his study Tan et al40measured choroidal thickness at 5 time points 
during daytime and found significant diurnal variations in choroidal 
thickness. They found that choroidal thickness was thickest during early 
morning and decreased as the day passed and was thinnest at around 5PM. 
THERAPEUTIC: 
Pan -Retinal photocoagulation: 
          In Pan retinal photocoagulation the retinal pigment epithelium is the 
main site of heat absorption. The heat dissipated from the retinal pigment 
epithelium cells causes damage to the outer retina and choroid. The 
damaged choroid failed to reperfuse thus becoming fibrosed leading to 
thinning of choroid.34 
     Studies have shown the effect of choroid at 1 week and 3 months post 
pan retinal photocoagulation. Cho et al41 measured choroidal thickness in 
patients 1 week post PRP where he found the choroidal thickness to be 
increased. The increase in thickness was attributed to increase in choroidal 
 
 
blood  flow due to vasodilatation or choroidal effusion induced by possible 
choroidal vascular obstruction by the laser photocoagulation  . 
Unsal et al42 measured choroidal thickness  3 months post PRP where 
he found that the choroid was thinner. 
Intravitreal Injections: 
Studies43-44have shown that there is a reduction in the thickness of the 
choroid following intravitreal injections. It was postulated that anti VEGF 
penetrates all layers of retina and accumulates in the choroidal vessel wall 
.Anti VEGF causes constriction of choroidal vessels and decrease in 
choriocapillaris causing thinning of the choroid.           
Ocular Causes: 
 Myopia: 
             Choroidal thickness is decreased in high myopes. Fujiwara et al 45 
stated that Choroidal thickness decreases as age advances and this may play 
a role in choroid atrophy and the pathogenesis of decreased vision in high 
myope. 
              They also state that although both retina and choroid are thinned in 
high myopia, choroid may still be able to supply the thinned retina with 
adequate oxygen and nutrients. 
 
 
Spaide et al4 showed that for every ten years of life subfoveal 
choroidal thickness decreased by 12.7 micrometers .The Choroidal 
thickness (CT) also decreased by 8.7 micrometers for increase in each 
diopter of myopia. This was important as it suggested that abnormality of 
the choroid may play a role in the pathology of myopic degeneration. 
Glaucoma: 
               Yin et al46 proposed in his study on 25 postmortem Primary open 
angle glaucoma eyes  and 18 age matched normal eyes found that choroid 
was 50 micrometers thinner. 
The choroidal thinning was associated with vessel loss occurring 
mostly  the inner choroidal level. It was also found that there was an overall 
reduction in the diameter of the vessel. 
Cataract surgery:  
Pierru et al47 in his study of 115 eyes of 95 patients who had 
undergone phacoemulsification has shown that there is an increase in 
choroidal thickness. The choroidal thickness was more in post operative day 
one and seven. 
 
 
 
The increase in choroidal thickness was attributed to the release of 
prostaglandins in the anterior chamber where it caused blood aqueous 
barrier to breakdown resulting in the pro–inflammatory mediators 
accumulation which moved into the posterior segment and caused 
inflammation in the retina by breakdown of inner blood retinal barrier. 
There was also increase in the permeability of perifoveal capillaries. 
Choroidal pathology: 
Central serous chorioretinopathy: 
Imamura48 in his study comprising of 19 patients with central serous 
chorioretinopathy proved that there was a significant increase in choroidal 
thickness. This increase was attributed to the increase in hydrostatic 
pressure of the choroid 
Age related macular degeneration: 
In his study on choroidal thickness in age related macular 
degeneration Manjunath et al49 noted that the choroidal thickness increases 
in some eyes and decreases in others. 
It was found that in Age related macular degeneration there was a 
reduction in choroidal blood flow and it further decreased as the disease 
progressed. The decreased flow was attributed to multiple factors: 
 
 
choriocapillary narrowing, loss of cellularity and  choroidal thinning 
especially in the choriocapillaris. Vasoconstriction and hypoxia also 
happens due to increased levels of nitric oxide.  
Choroidal atrophy: 
In his study Spaide et al4 established a new clinical entity, Age related 
choroidal atrophy where he found that the subfoveal choroidal thickness 
was reduced as well as nasally. All the patients in that particular study group 
were also found to have a tessellated fundus appearance. It was also found 
that the choroidal vessels sub foveally in those patients were also reduced 
thus having a negative influence on vision. 
Retinitis Pigmentosa: 
Retinitis pigmentosa there is a primary vascular dysfunction including 
reduced choroidal as well as retinal blood flow which leads to photoreceptor 
damage. Research has shown that the eyes with retinitis pigmentosa tend to 
have a choroid which is thinner (both focal and diffuse thinning is present). 
  
 
 
OPTICAL COHERENCE TOMOGRAPHY:50 
Introduction: 
It is new diagnostic essential tool which can perform cross sectional 
imaging of biologic tissues.  
In ocular tissues, it helps greatly invivo analysis of retinal tissue for 
diagnosis and management of retinal disorders and other conditions like 
glaucoma. 
Principles of OCT: 
 
FIG 17. PRINCIPLE OF OCT 
 
 
It is a technique to detect differences between two  (interfering)  or 
more superimposing waves.  
Interferometry works in such a way that two waves with the same 
frequency and having similar phase will add each other. In the same 
principle two waves with opposite phases will subtract. 
Light from a source is directed onto a partially reflecting mirror and is 
split into a reference and a measurement beam. 
The measurement beam is reflected from the specimen with different 
time delays according to its internal microstructure. 
A variable time delay is produced when the light in the reference 
beam is reflected from a reference mirror at a variable distance. 
Multiple echoes from the specimen and a single echo from the 
reference mirror at a known delay are combined and detected 
The detected signal contains information on the position of the 
scatters within the sample, on their reflectivity, velocity and polarization 
properties. By this collection of depth scans from the sample three 
dimensional construction of cross-sectional images is possible. 
 
 
 
 
Evolution of OCT: 
Time domain OCT: 
Here a reflected beam of light is compared to a beam of light from a 
moving reference mirror wherein time delay between the two beams can be 
measured . 
Features: 
A –  Scan generated sequentially one pixel at a times of 1.6 seconds.  
                Moving reference mirror 400 scans/second 
                Resolution -10 micron 
Slower than eye movement. 
 
 
 FIGURE 18. TIME DOMAIN AND SPECTRAL DOMAIN OCT
 
  
 
 
 
 
 
Spectral Domain OCT: 
Here a spectrometer is used in place of a single detector. The 
difference in wavelength between the light from the fixed reference arm and 
that returning from the tissue is measured using a spectrometer. 
In Spectral domain OCT there is no movement of the reference arm 
and instead the reflected light is analysed using a spectrometer. The 
wavelength of the light source is 840 nm. 
The immediate advantage of the technology is the high number of 
scans required per second –approximately 27,000 A-scans per second 
making true three dimensional imaging possible. 
Advantages of Spectral domain OCT: 
1. Simple 
2. Reliable 
3. Sensitive (resolution of 5 microns) 
4. Reproducible 
Swept Source OCT: 
The source laser rapidly sweeps across the spectral frequency   band. 
At the beam splitter the reflected signals from the sample and reference arm 
 
 
(fixed) are combined and directed at the detector after which an axial scan is 
constructed from depth resolved spectral interference signals. 
 
FIG 19. SPECTRAL DOMAIN AND SWEPT SOURCE OCT 
 
 
 
 
Enhanced depth  imaging OCT:4 
 
FIG 20. HEIDELBERG SPECTRALIS OCT 
EDI was pioneered by ophthalmologists Ron Margolis, MD, and 
Richard F. Spaide, MD, in 2009. Before their work, it was impossible to 
visualize the choroid by OCT because of:  
1. The pigmented RPE acted as a barrier because of which penetration 
of light was poor. 
2. Light scatter by the choroidal vasculature itself.  
 
 
Using the Spectralis (Heidelberg Engineering), Dr. Margolis and 
Dr.Spaide found that they could more effectively view the choroid by 
inverting the image. Originally, they accomplished this by simply 
positioning the patient slightly closer to the machine. By convention, the 
zero delay line is located at the top of the imaging screen and represents the 
area of most precise focus. By inverting that image, the chorioscleral 
interface is placed near the zero delay line, improving the scan quality of the 
deeper, posterior structures. EDI-OCT penetrates an additional 500µm to 
800µm deeper compared with traditional OCT imaging.   
Applications of OCT: 
Ø Retinal profiles seen with OCT: 
Ø Normal profile 
Ø Enlarged foveal depression 
Ø Decreased foveal depression 
Ø Asymmetric foveal depression 
Ø CSCR 
Ø ARMD 
Ø Diabetic Retinopathy 
Ø Macular Hole 
Ø Treatment of epiretinal membrane 
 
 
Ø To assess treatment response in glaucoma patients by analysing ONH 
and NFL thickness. 
 
 
FIG  21. CHOROID MEASURED FROM HYPEREFLECTIVE RPE 
TO THE CHORIOSCLERAL INTERFACE 
 
 
 
 
Measurement of choroid using EDI OCT: 
Choroid is measured from the hypereflective Retinal pigment 
epithelium to the chorioscleral interface.4,34,35 The choroid is thicker under 
the fovea and is thinner nasally than temporally. Choroidal thickness 
measurements in normal subjects appear to be highly reproducible. 
  
 
 
REVIEW OF LITERATURE: 
1.) Choroidal thickness in Patients with Diabetic retinopathy: Unsal 
et al ,2014 
Retrospective cross sectional research where 151 eyes from 8o 
patients with DR and 40 eyes of 20 healthy individuals. The DR patients 
were grouped into, Mild – moderate NPDR with Macular oedema and 
proliferative diabetic retinopathy. 
Choroidal thickness was measured using an optovue  RTVue 100-2. 
They came to a conclusion that Choroidal thickness was found to be 
significantly decreased in DME (206.8 micrometers) and PDR (203.8 
micrometers) groups when compared with normal group (259 micrometers)  
 
2.) Choroidal thickness profile in healthy Indian subjects:          
Chhablani et al ,2014 
In this first study of choroidal thickness in Indian population, 211 
eyes of 115 healthy subjects participated were involved. 
Cirrus HD OCT was used to measure the choroidal thickness from 
RPE to the chorioscleral interface at junctions of 500 micrometers nasally 
and temporal to fovea for about 3000 micrometers. 
 
 
The study concluded that Subfoveal choroid was the thickest and 
nasal being the thinnest. It also stated that age is a critical factor which has a 
negative correlation to choroidal thickness. 
3.) Measurement of subfoveal choroidal thickness after cataract 
surgery in enhanced depth imaging optical coherence 
tomography. Pieurru et al ,2014 
This study compared the sub-foveal choroidal thickness before and 
after phacoemulsification. Measurement of the subfoveal choroidal 
thickness in 95 patients were performed preoperatively and 1 day , 7 days ,1 
month and 3 months postoperatively. 
They concluded that choroidal thickness was found to be increased 
under the fovea after cataract surgery. They also found that the changes 
were greater in pseudophakic cystoid macular oedema cases.  
4.) Changes of choroidal thickness after treatment for    Diabetic 
retinopathy: Lee et al ,2014 
This study included 31 eyes in the intravitreal bevacizumab group and 31 
patients in the PRP group and 35 eyes in the intravitreal and PRP group. 
In this study Enhanced depth imaging was done one month before each 
treatment to measure subfoveal and extrafoveal choroidal thickness. The 
BCVA and central macular thickness was also measured. 
 
 
They came to a conclusion that choroidal thickness was significantly 
decreased in all group but there was no significant change among the three 
groups. The subfoveal choroidal thickness and Central macular thickness 
were significantly reduced after Intravitreal bevacizumab and Intravitreal – 
PRP group. 
5.) Analysis of morphological features and vascular layers of choroid 
in diabetic retinopathy using spectral domain optical coherence 
tomography:Adhi et al, 2013 
This study was a cross sectional retrospective review. 33 eyes of patients 
with DR and twenty four eyes of twenty four controls participated in this 
study. Subjects were split into 3 groups : NPDR with DME, PDR with DME 
and DME alone.  
Spectral domain OCT (cirrus-HD) was used for measuring the choroidal 
thickness. 
They concluded that Sub foveal choroidal thickness, subfoveal 
medium choroidal vessel layer and choriocapillaris thickness were  reduced 
markedly in   Proliferative DR , Diabetic Macular oedema.   
 
 
 
 
6.) Changes in choroidal thickness in relation to severity of 
retinopathy and macular oedema in type 2 diabetic patients, Kim 
et al 2013 
In this study 235 eyes from 145 patients ,195  eyes which had no 
ocular treatment and 40 eyes with prior history of PRP done for PDR were 
divided into no DR, Mild/Moderate nonproliferative DR (NPDR) ,severe 
NPDR ,PDR and PRP treated eyes. 
The CT was measured using the Heidelberg spectralis OCT. They 
came to a conclusion that the choroid was significantly thicker in DME than 
other DR groups and that the severity increased as it progressed from Mild 
NPDR to PDR and the choroid was thinner in PRP treated eyes. 
7.) Changes in Sub foveal choroidal thickness after argon laser 
panretinal photocoagulation: Cho et al, 2013 
A prospective comparative case series where subfoveal choroidal and 
macular thickness was measured one week post pan retinal 
photocoagulation (after 3 sessions) using enhanced depth imaging spectral 
domain –OCT. 
    28 eyes of 21 patients with severe diabetic retinopathy were involved 
in this study. Pre and post PRP (1 week) choroidal and macular thickness 
were measured. 
 
 
     They concluded that there was an increase in subfoveal choroidal 
thickness. There was no correlation with changes in macular thickness. 
8.) Choroidal thickness in relation to hypercholesteremia on 
enhanced depth imaging optical coherence tomography: Wong et 
al, 2013 
A cross sectional observational study. A total of 322 eyes of 161 
subjects were analysed. The subjects were divided into those having 
hypercholestremia and normal control subjects. Choroidal thickness was 
measured using Heidelberg software at 4 locations (1mm superior, inferior, 
nasal and temporal) to the fovea. 
They concluded that choroidal thickness was significantly higher in 
Patients with hypercholestremia (306 micrometers) than normal subjects 
(258 micrometers). 
9.) Choroidal thickness in patients with diabetic retinopathy 
analysed by spectral Domain optical coherence 
tomography:Regatieri V et al ,2012 
In this study 49 eyes of 49 Diabetic retinopathy patients and 24 aged 
matched normal subjects were taken. They were split into 3 groups: 
Mild –moderate DR with no DME, Mild –Moderate DR with DME 
and  treated Proliferative DR without DME. 
 
 
The choroid was measured using spectral domain OCT from the 
posterior edge of the retinal pigment epithelium to the chorio-scleral 
interface. 
They concluded that choroidal thickness is altered according to the 
grade of retinopathy. Choroidal thickness is significantly reduced in the 
presence of DME.   
10.) Diurnal Variation of choroidal thickness in Normal, healthy 
subjects measured by spectral domain optical coherence 
tomography:Tan et al, 2012 
        A prospective study of 12 healthy individuals where each of them 
underwent sequential ocular imaging at five fixed two hour time intrevals. 
They concluded that the choroidal thickness was more in the morning and is 
correlated with age, axial length refractive error and changes in systolic 
pressure. 
11.) Analysis of choroidal thickness in age related Macular 
degeneration using spectral domain optical coherence 
tomography; Manjunath et al, 2011 
In this cross sectional retrospective study 47 patients with wet and dry 
age related macular degeneration were included in this study. Choroidal 
thickness was measured by two independent observers . 
 
 
They concluded that the patients with AMD may show variable 
choroidal thickness. They also stated that it was unclear why the choroid 
was thinner in certain eyes and vice versa. 
12.) Enhanced depth imaging optical coherence tomography of 
choroid in central serous chorioretinopathy ;Imamura et al ,2009 
This study evaluated the choroidal thickness in patients with central 
serous chorioretinopathy. 
In this study 28 eligible eyes of 19 patients with Central serous 
chorioretinopathy underwent EDI –OCT. The subfoveal choroid was 
measured from the hyperreflective RPE to the inner scleral border. 
It was found that the choroid was significantly thickened (505 
micrometers) 
13.) Enhanced Depth Imaging Optical Coherence Tomography of the 
Choroid in Highly Myopic Eyes: Fujiwara et al, 2008 
  This study measured macular choroidal thickness in highly myopic 
eyes using EDI –OCT were obtained by positioning a spectral domain OCT 
device close enough to the eye to acquire an inverted image. Choroidal 
thickness was measured from outer border of the RPE to the chorioscleral 
interface. The temporal and nasal choroidal thickness was measured at 100 
 
 
micrometers intrevals of a horizontal section 3mm temporal and 3mm nasal 
to the fovea. 
              They concluded that the choroid in highly myopic eyes is thinner 
and undergoes further thinning with age and degree of myopia. They also 
postulated that abnormalities of the choroid may play a role in the pathology 
of myopic degeneration. 
14.) Widespread choroidal insufficiency in Primary Open angle 
glaucoma;1997 
This study investigated choroidal perfusion in glaucoma using 
histological and angiographic techniques. 
In this study choroidal vasculature in 25 cases of Primary open angle 
glaucoma was examined with clinicopathalogical studies. Choroidal 
thickness was measured at fixed distances from the disc margin using light 
microscopy. 
The study concluded that choroid was significantly thinner (50 
micrometres thinner) in glaucoma than in normal patients. 
 
 
 
 
15.) Choroidal thickness measured by spectral domain optical 
coherence tomography:Factors affecting thickness in glaucoma 
patients; Maul et al, 2011 
A cross sectional study to measure choroidal thickness in 74 
glaucoma and glaucoma suspects using EDI-OCT 
It was concluded that the macular choroid was significantly thinner in 
association with 4 features like longer eyes, with age, lower diastolic 
perfusion pressure and thicker central corneas. 
16.) Alterations in the choroid in hypercholestremic rabbits: 
Reversibility after normalization of cholesterol levels. Salazar et 
al,2007 
       This study evaluated the effect of choleseterol in rabbits who were fed 
with cholesterol enriched diet for 8 months. 
    It was found that the choroidal thickness was more in 
hypercholestremic rabbits and that the choroidal changes were irreversible 
once the cholesterol levels were controlled. 
 
 
 
 
 
17.) Choroidal Blood Flow Compensation in Rats for Arterial Blood 
Pressure Decreases is Neuronal Nitric Oxide-Dependent but 
Compensation for Arterial Blood Pressure Increases is not; 
Reiner et al 
In this study, Reiner et al investigated whether Choroidal Blood flow 
can compensate for increases and decreases in Arterial Blood Presuure in 
rats. Choroidal Blood flow was continuously monitored using laser Doppler 
flowmetry in anesthetized rats, and Arterial blood pressure was measured 
through the femoral artery. Choroidal blood flow and arterial blood flow 
were sampled at multiple intervals over a 2-4 hour period during which 
ABP varied freely, and the results compiled across rats. 
  Choroidal Blood Flow was found to be near baseline over an ABP 
range from 40 mmHg above basal ABP (90-100 mmHg) to 40 mmHg below 
basal ABP. Choroidal blood flow largely followed ABP linearly below 60 
mmHg. As BP increased above 100 mmHg , choroidal vascular resistance 
increased linearly and decreased linearly as BP declined from basal to 60 
mmHg. But resistance declined no further below 60 mmHg. Inhibition of 
nitric oxide (NO) formation by either a selective inhibitor of neuronal nitric 
oxide synthase (NOS) (N ω-propyl-L-arginine) or a nonselective inhibitor of 
both neuronal NOS and endothelial NOS (N ω-nitro-L-arginine methyl 
ester) did not affect compensation above 100 mmHg ABP. But ChBF  
 
 
linearly follow declined as BP fell below 90 mmHg. In NOS-inhibited rats, 
with BP above 100mmHg, choroidal vascular resistance increased but 
remained at baseline below 90 mmHg. 
18.) Effects of a human VEGF antibody (Bevacizumab) on 
deprivation myopia and choroidal thickness in the chicken; 
Mathis et al ;2014 
This study was done to study the effect of Bevacizumab on choroidal 
thickness and deprivation myopia in chicken. 
  It was found that: 
1.) Following a single unilateral intravitreal injection of 0.5 mg 
bevacizumab, it partially suppressed the development of deprivation 
myopia, similarly in both eyes. 
2.) Bevacizumab completely suppressed choroidal thickening that 
normally occurs when eyes recover from induced myopia over a time 
period of about 10 days  
3.) Beavacizumab had little effect on the choroidal thickness in eyes that 
had normal visual experience 
4.) VEGF-A was absent in sclera. But it was found to be highly 
expressed in the walls of choroidal blood vessels and presumed nerve 
 
 
fiberbundles. It was also found in retinal photoreceptors and cells of 
the inner and outer nuclear layer.  
In conclusion, Bevacizumab is equally effective in human and chicken 
tissue, has similar time constants (few days), has almost symmetrical effects 
on myopia in both eyes even after ocular application in only one eye. It was 
also found that it fully suppresses choroidal thickening that normally 
follows during recovery from deprivation myopia. 
  
 
 
AIMS AND OBJECTIVES  
AIM: 
         To measure and compare the subfoveal choroidal thickness in various 
stages of Diabetic retinopathy and normal participants using enhanced depth 
imaging optical coherence tomography 
OBJECTIVES:   
      To measure and compare the subfoveal choroidal thickness in various 
stages of  Diabetic retinopathy with  normal participants and to correlate the 
subfoveal choroidal thickness with severity of DR. 
 
  
 
 
MATERIALS AND METHODS 
This study was conducted with the approval of the local ethics committee 
Abiding the tenents of the  declaration of Helsinki. Study Period : December 
2014 – May 2015  
    All the patients included in this study [21 diabetic patients (42 eyes) 
and 46 eyes of 25 control patients)] underwent complete ophthalmic 
examination including refraction ,best corrected visual acuity and 
Intraocular pressure measured by non contact tonometry. The patient 
underwent dilated 90 dioptre slit lamp examination and Diabetic retinopathy 
grading was done using the ETDRS classification.  The patients were split 
into Mild –Moderate NPDR, Severe NPDR, PDR ,CSME groups. 
           All known cases of Diabetes mellitus on treatment were included in 
this study. Exclusion criteria included patients with other systemic illness 
,previous history of intravitreal injections or PRP, High myopia (more than -
3 diopters) hypermetropia more than +3 diopters, Factors affecting choroid 
like (age related macular degeneration ,central serous chorioretinopathy, 
polypoidal choroidal vasculopathy ), glaucoma and patients who underwent 
cataract extraction beyond 6months.  All patients underwent EDI – OCT. 
Patients where the chorioscleral interface was less than grade 1 were not 
included in the study. 
 
 
 
INCLUSION AND EXCLUSION CRITERIA: 
INCLUSION CRITERIA EXCLUSION CRITERIA 
Type 2 Diabetes mellitus  Hypertension, Hypercholestremia, 
Renal failure 
Media where the posterior 
segment is clearly visible 
High myopia (more than -3 D), 
Hypermetropes  (+3 D) 
 choroidal pathology, Glaucoma 
 History of ocular surgeries, 
Intravitreal inj or LASER 
 
INSTRUMENTATION: 
              All choroidal thickness measurements were done using the 
SPECTRALIS HRA + OCT platform (Heidelberg Engineering Inc, 
Heidelberg, Germany). All patients also underwent Auto fluorescence and 
fundus photography. 
  
 
 
SPECIFICATIONS : 
Light source ICG excitation: 
Diode laser, wavelength 790 nm,laser class 1 
IR reflectance: 
Diode laser ,wavelength 820 nm, Laser class 1 
FA excitation and Blue reflectance: 
Solid state laser ,wavelength 488 nm, laser class 1 
Super luminescence diode (SLD) average 
Wavelength 870 nm ,LASER class 1 
Scanning LASER 
Specifications 
Transverse field of view  
Scan angle: 30°x30°, 20°x20°, 15°x15°  
Wide field composite image to 120°  
High speed mode  
Digital image size: 768x768 / 512x512 / 384x384.  
High resolution mode Digital image size: 1536x1536 
/ 1024x1024 / 768x768.  
Scan time per image: 192 ms / 128 ms / 96ms. Lateral 
resolution 5 µm/pixel digital Image Acquisition 
Frequency 5 Hz / 7 Hz / 9 Hz Maximum Scan Depth 
8 mm 
OCT scanner 
specifications: 
A-Scan  scan rate: 40 KHz 
Scan depth :1.8 mm 
Scan size:  512 pixels axial resolution: 7 micrometre 
optical 
B-scans scan angle:30/15/10 degree 
Scan width : upto 9mm 
High speed mode scan width :768 A-scan 
Acquisition time: 19 ms scan rate : 48 B scans /sec 
High resolution mode scan width: 1,536 A-scan 
Focus adjustment  
range 
-12 diopters to +12 diopters spherical 
 
 
 
 
IMAGING PROTOCOL: 
 The same clinician performed EDI-OCT imaging of all subjects in 
the morning (between 9 am and 4pm) with Heidelberg Spectralis equipment 
(Heidelberg Engineering Inc, Heidelberg, Germany). 
PROTOCOL FOR CHOROIDAL THICKNESS MEASUREMENT: 
Scan Angle: 30°X15° 
Sections : 19 
ART: 100 
Mode: Enhanced-Depth imaging 
HIGH-RESOLUTION MODE  
 
FIG 21. PARAMETERS FOR EDI OCT 
 
 
Subfoveal choroidal measurement: 
The subfoveal choroid is measured from the Hyper-reflective line of 
the RPE-Bruch’s membrane complex to the chorioscleral interface which 
forms the posterior boundary. The region of the centre of the fovea was 
identified as the area of maximum depression. 
The parafoveal nasal and temporal measurements were done at 500 
micrometres on each side from the centre of the fovea. The choroidal 
thickness was measured using the caliper tool available in the Spectralis 
platform. 
 
Fig 22. EDI OCT MEASUREMENT OF A DIABETIC EYE. 
  
 
 
 
MILD NPDR 
 
MODERATE 
NPDR 
 
SEVERE NPDR 
PDR 
 
SUBFOVEAL CHOROIDAL THICKNESS MEASUREMENT IN 
VARIOUS STAGES OF DR 
 
 
 
Chorioscleral interface grading: 
All OCT images were graded into four categories based on the 
visibility of the chorioscleral interface along the entire length of the scan. 
OCT images with signal strength less than 6 dB and CSI grade less than one 
were excluded from study 
 
Grade 1: 25% of CSI seen 
 
Grade 2: 25-50% CSI seen 
 
Grade 3: 50 -75% seen 
 
Grade 4: >75% seen 
 
 
STATISTICAL ANALYSIS 
AGE 
Group n Mean(SD) Min – Max P-value 
Diabetic 
retinopathy 
21 56.05(4.7) 49 – 65 
0.0001 
Normal 25 47.24(8.3) 33 – 67 
 
Age Category DR Normal Total 
<= 40 - 5(20.0) 5(10.9) 
41 – 50 4(19.0) 13(52.0) 17(37.0) 
51 – 60 13(61.9) 5(20.0) 18(39.1) 
>60 4(19.0) 2(8.0) 6(13.0) 
Total 21 25 46 
 
Mean age was higher in Diabetic Retinopathy group compare to 
normal group, it was also statistically significant difference (P-value = 
0.0001, using t-test).  Also 62% of the patients were 51 – 60 age limits in 
DR group and 52% of the patients were 41-50 age limits in normal group.  
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 GENDER 
Gender 
Group
Normal 
(n=25 
patients) 
Male 12(48.0) 
Female 13(52.0) 
 
48% of the patients were male in
patients were male in DR group.  It was not showing statistically significant 
difference between groups (P
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Total 
(n=46 
patients) 
P 
Diabetic 
Retinopathy 
(n=21 patients) 
16(76.2) 28(60.9) 
0.051
5(23.8) 18(39.1) 
 Normal group and 76% of the 
-value = 0.051, using chi-square test). 
Normal
48
24
52
Gender
Male Female
- value 
 
 
 RBS  
 The Mean (SD) of RBS is 196.76(84.64)mgs% & its range is 101 
375 mgs%.  12(57%) patients had more than 160 
RBS 
<= 160 
> 160 
Total 
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RBS level in DR group.
n % 
9 42.9 
12 57.1 
21 100 
>160
42.9
57.1
RBS
- 
 
 
 DURATION OF DIABETES
The Median of Duration of Diabetic is 7 years & its range is 15 days 
13 years.  12(57%) patients had more than 5 
Duration of Diabetic 
<= 5 years 
> 5 years 
Total 
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year diabetes in DR group.
n % 
9 42.9 
12 57.1 
21 100 
>5 years
42.9
57.1
- 
 
 
 GRADE OF DR 
Grade of DR 
Mild NPDR 
Moderate NPDR 
Severe NPDR 
PDR 
Total 
 
26% of eyes had mild NPDR, 57% of eyes had moderate NPDR, 7% 
had Severe NPDR and 9.5% had PDR.  
 
Moderate NPDR
57%
Severe NPDR
7%
PDR
10%
 
n % 
11 26.2 
24 57.1 
3 7.1 
4 9.5 
42 100 
 
Mild NPDR
26%
Grade
 
 
 
CHOROIDAL THICKNESS 
Choroidal 
Thickness 
Group 
Total 
(n=88 eyes) 
P - value 
Normal 
(n=46 eyes) 
Diabetic 
Retinopathy 
(n=42 eyes) 
Sub foveal 
Mean(SD) 
 Min - Max 
 
311.32(68.2) 
207 - 476.5 
 
260.00(33.9) 
198 - 344 
 
286.82(60.1) 
198 - 176.5 
<0.001 
Nasal 
Mean(SD) 
 Min - Max 
 
274.54(71.9) 
147 - 456.5 
 
232.31(31.7) 
169 - 324 
 
254.16(59.8) 
147 - 456.5 
0.0007 
Temporal 
Mean(SD) 
 Min - Max 
 
258.26(70.7) 
147 - 432 
 
242.12(33.0) 
162 - 337 
 
250.47(56.1) 
147 - 432 
0.1729 
 
Mean sub foveal thickness was 260.00 in Diabetic Retinopathy group 
and 311.32 in Normal group, it was also statistically significant difference 
between group (P-value<0.001, using t-test).  Mean Nasal thickness was 
232.31 in Diabetic retinopathy group and 274.54 in normal group, it was 
also statistically significant different between groups (P-value=0.0007, 
using t-test).  Mean temporal thickness was 242.12 in Diabetic retinopathy 
group and 258.26 in normal group, it was showing not statistically 
significant different between groups (P-value=0.173, using t-test).  Category 
of choroidal thickness was shown in below table. 
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thickness 
<=300 
>300 
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CHOROIDAL THICKNESS IN VARIOUS STAGES OF DR 
Choroid  
Thickness 
DR stages [ Mean(SD) ] 
Total 
(n=42 eyes) 
Mild NPDR 
(n=11 eyes) 
Moderate 
NPDR 
(n=24 eyes) 
Severe 
NPDR 
(n=3 eyes) 
PDR 
(n=4 eyes) 
Sub foveal 
Mean(SD) 
 Min - Max 
238.91(20.4) 
200 - 272 
257.42(31.3) 
198 - 320 
287.33(9.7) 
279 - 298 
313.00(23.1) 
293 - 344 
260.00(33.9) 
198 - 344 
Nasal 
Mean(SD) 
 Min - Max 
220.27(26.0) 
169 - 265 
227.25(26.0) 
189 - 279 
253.00(27.8) 
228 - 283 
280.25(40.0) 
227 - 324 
232.31(31.7) 
169 - 324 
Temporal 
Mean(SD) 
 Min - Max 
222.55(28.7) 
162 - 275 
240.42(26.7) 
192 - 293 
266.67(16.9) 
255 - 286 
287.75(41.2) 
242 - 337 
242.12(33.0) 
162 - 337 
 
Mean Subfoveal thickness was 238.91, 257.42, 287.33 and 313 in 
mild NPDR, moderate NPDR, Severe NPDR and PDR respectively.  Mean 
Nasal thickness was 220.27, 227.25, 253.00 and 280.25 in mild NPDR, 
moderate NPDR, Severe NPDR and PDR respectively.  Mean temporal 
thickness was 222.55, 240.42, 266.67 and 287.75 in mild NPDR, moderate 
NPDR, Severe NPDR and PDR respectively.  All these three choroidal 
thicknesses was increase as severity of DR stage was increase . 
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CHOROIDAL THICKNESS IN CSME 
Choroid  
Thickness 
CSME [ Mean(SD) ] 
P - value Present  
(n=8 eyes) 
Absent 
(n=34 eyes) 
Sub foveal 
Mean(SD) 
     Min - Max 
 
284.38(19.8) 
257-320 
 
254.26(34.1) 
198-344 
0.022 
Nasal 
Mean(SD) 
     Min - Max 
 
245.38(24.2) 
215-283 
 
229.24(32.8) 
169-324 
0.199 
Temporal 
Mean(SD) 
     Min - Max 
 
259.88(19.5) 
229-286 
 
237.94(34.4) 
162-337 
0.091 
 
Mean subfoveal thickness was 284.38 in CSME and 254.26 in Non-
CSME.  It was showing statistical difference between CSME and Non-
CSME group (P-value=0.022, using t-test).  Mean Nasal thickness was 
245.38 and 229.24 in CSME and Non-CSME group, there was no statistical 
difference (P-value=0.199, using t-test).  Mean temporal thickness was 
259.88 and 237.94 in CSME and non-CSME group respectively, it was not 
showing statistically significant difference (P-value = 0.091, using t-test).   
 
 
 
 
Choroidal 
Thickness 
CSME NORMAL P-value 
Subfoveal µm 
Mean (SD) 
Min-Max 
 
284.38 
257-320 
 
311.31 
207 -476.5 
 
0.276 
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DISCUSSION 
Choroid is an important vascular tissue which supplies the outer RPE 
and photoreceptors. The main functions of choroid are:  
1. Thermoregulation, 
2. Changes in choroidal thickness may change the position of the retina 
3. Secretion of growth factors.  ( It play a role in emmetropization, ie: It 
helps in the adjustment of eye shapeduring growth to correct myopia 
or hypermetropia.)18 
        The choroid is the mainstay for blood supply to the retina. During 
nocturnal periods the photoreceptors consume more oxygen and that is 
supplied by the choroid (90 %) 18.The blood flow in the choroid is the 
highest of any tissue in the body.  The high transport of oxygen from the 
choroid, despite the barriers of Bruch's membrane and the retinal pigment 
epithelium is because of this high blood flow. 18 
 In humans, at birth the choroid is approximately 200 μm thick and by 
90 years of age it decreases to around 80 μm51. Spaideet al4 in his study 
found that the choroidal thickness decreases with age. Studies have also 
proven that certain conditions affect the choroidal thickness. 
       In diabetes, Studies have shown that the choroid is also involved and 
that diabetic choroidopathy can be used as a predictor for the occurrence of 
Diabetic retinopathy. 2,53 
 
 
 Weinberger et al2 showed that by FFA that both hyper and 
hypoflourescent spots were present in diabetic patients at the choroidal 
level. Pathologic findings included increased  blood vessel tortuosity, focal 
vascular dilatation and narrowing, hypercellularity, vascular loops and  
formation of microaneurysm, nonperfused areas.There was also formation 
of  sinus-like structure between the choroidal lobules. In the same study 
using ICG they described a salt and pepper appearance of the choroid which 
indicated delayed filling of the choriocapillaris, suggesting that there was 
presence of ischemia. It further proved the presence of diabetic 
choroidopathy which could be an predictor of retinal involvement. Zaharia 
et al52 in his study noted that there is delayed choroidal lobular filling in 
diabetic patients even before clinical appearance of DR suggesting that there 
choroidal involvement before the retina in involved. 
Nagoka et al27 in his study on choroidal blood flow in the foveal 
region of diabetic patients found that the flow is decreased in early NPDR 
stages and was very much decreased in patients with diabetic macular 
edema. He also stated that the changes occurring in the choriocapillaris may 
occur well before the onset of diabetic retinopathy. 
Hidayat et al3 in his study noted that there was significant narrowing 
of the choriocapillaris in type 1 diabetic patients. Choroidal compromise 
was attributed to  
 
 
1. Capillary drop-out with or without fibrosis  
2. Basement membrane accumulation causing significant luminal 
narrowing of the choriocapillaris. 
3. Endothelial hypertrophy in eyes with severely advanced disease. 
  Savage et al54 on his study on pulsatile blood flow in various stages of 
DR showed that the Pulsatile ocular blood flow increased from mild to 
severe NPDR. The choroidal blood flow was found to be elevated in these 
groups but decreased in PRP treated eyes. Studies also found that the rise in 
choroidal blood flow mirrors the increase in renal blood flow 55-56 in 
moderate to severe NPDR. 
Chhablani et al56 in his study on normal Indian population found that the 
choroid was thickest subfoveally and thinnest nasally. He also found that 
CT had an negative correlation with age. 
Unsal et al42 in his study which was a   Retrospective cross sectional 
research where 151 eyes from 8o patients with DR  and 40 eyes of 20 
healthy individuals. The DR patients were grouped into NPDR, Mild – 
moderate NPDR with Macular edema and proliferative diabetic retinopathy. 
  Choroidal thickness was measured using an optovueRTVue 100-2. 
They came to a conclusion that Choroidal thickness was found to be 
significantly decreased in DME (206.8 micrometers) and PDR (203.8 
micrometers) groups when compared with normal group (259 micrometers).  
 
 
Kim et al1 in his study on 235 eyes from 145 patients ,195  eyes 
which had no ocular treatment and 40 eyes with prior history of PRP done 
for PDR were divided into no DR, Mild/Moderate nonproliferative DR 
(NPDR) ,severe NPDR ,PDR and PRP treated eyes. 
The choroidal thickness was measured using the Heidelberg spectralis 
OCT. They came to a conclusion that the choroid was significantly thicker 
in DME than other DR groups and that the severity increased as it 
progressed from Mild NPDR to PDR and the choroid was thinner in PRP 
treated eyes. 
Regatieri et al35 in his study on 49 eyes of 49 Diabetic retinopathy 
patients and 24 aged matched normal subjects where the patients were split 
into 3 groups: Mild –moderate DR with no DME, Mild –Moderate DR with 
DME and  treated Proliferative DR without DME.The choroidal thickness 
was measured using Cirrus HD OCT. 
 They concluded that choroidal thickness is altered in relation to the 
severity of retinopathy. Choroidal thickness is significantly reduced in the 
presence of DME. 
Adhi et al34 in his study where 33 eyes of patients with DR and 24 eyes 
of 24 controls were included in his study. Patients were split into 3 groups : 
NPDR with DME, PDR with DME and DME alone. 
 
 
Spectral domain OCT (cirrus-HD ) was used for measuring the 
choroidal thickness. They concluded that Sub foveal choroidal thickness, 
subfoveal medium choroidal vessel layer and choriocapillaries thickness is 
reduced markedly in Proliferative DR , Diabetic Macular oedema.  
 In our study we found that the subfoveal choroid was thinner in the 
DR group than the control group (P<0.001) . We found that the thickness 
increased as the severity of the disease progressed as the severity 
progressed..The choroidal thickness was thinner in DR patients (260.00 
micrometres) than the control group (311.32micrometres).Among the DR 
patients the choroid was thicker in the PDR group (313 micrometres) and 
the DME groups (283 micrometres) . We also found that the choroid was 
thickest under the fovea and thinnest nasally than temporally .But in our 
study we had just taken one measurement at 500 micrometres. nasally and 
temporally. 
The mean subfoveal thickness is 238.91,257.42,287.33 and 313 µm in 
mild NPDR, moderate, severe NPDR and PDR respectively. This is 
significantly less than the thickness in the controls where the mean thickness 
was 311.32 µm.Similar results were shown in a study,where the SFCT was 
shown to be less than the controls.57Chabblani et al56 in his study has shown 
that choroidal thickness has been shown to be significantly related to age 
with an approximate decrease in CT of 1.18µm every year.Spaide et al57 in 
 
 
his study showed that there is a decrease in choroidal thickness by 15.6 
micrometres with each decade of life.In our studythe mean age of the 
control group was 47 years and the DR group was 56.05years, thus the 
control group was 9 years younger than the diabetics and hence the lesser 
choroidal thickness in the study cohort. 
Our study data shows that there has been a consistent increase in 
choroidal thickness with the increase in severity of DR which corroborates 
with the study findings of  Kim et al1.In his study, heattributed the thickness 
of these findings to an increased production of VEGF or other cytokines 
causing choroidal vasodilation as well as elevation in choroidal blood flow. 
These changes subsequently increased the thickness of the choroidal 
vascular layer, especially in patients with severe NPDR or PDR.Savage et 
al53 noted in his study that there was an increase in the choroidal blood flow 
as the severity of DR progressed thus contributing to the increase in 
thickness. 
The subfoveal choroidal thickness was more in the CSME group 
(284.38µm) as compared to the non CSME group (254.26µm) which is in 
accordance with the findings by Kim et al1,where thickness was more in the 
DME group as compared with the no DME groups. 
 
 
In this study we did not find any statistically significant difference between 
the subfoveal choroidal thickness in the CSME (284.38 µm) with diabetic 
retinopathy group and the controls (311 µm), which shows that in patients 
of CSME the CT increases which corroborates with other studies 1,57. 
But the findings of the present study have to be corroborated with a 
bigger sample size and age matched subjects in both arms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIMITATIONS 
1. Small sample size,particularly in the severe NPDR, CSME and PDR 
group. 
2. There was significant difference in the age of the normal and DR groups 
that may have an effect on the outcome of the finding that diabetic 
choroid is thinner. 
3. Hba1c was not used as an investigation to know the diabetic control of 
the patients enrolled in the study. 
4. Diabetic patients with no DR were not included in this study. 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
In conclusion this study shows EDI OCT has an important role in the 
assessment of choroid in various stages of DR. This study also shows that 
the choroidal thickness increases as the severity of DR increases. 
Further studies with a larger sample are necessary in wake of the 
findings of the present study so as to analyse the cause and effect 
relationship between DR grade and choroidal thickness by EDI OCT. 
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Choroid Thickness in Various Stages of DR 
Proforma for Thesis Study 
Name:                                                                   
MR NO:     Study No: 
Age:      Sex : 
Diabetic details:Other systemic illness:  
Duration of diabetes:                   HTN 
HBA1c:       Lipid Profile 
Details of Treatment:     Renal 
Ocular History: 
Any Surgery :   Yes              No                   
If yes when: Nature of Surgery: 
Any Intravitreal Injections/LASER: Yes                  NO           ,   If yes 
when: 
Using Ocular Medications:  Yes 
Ocular Examination: 
BCVA:  RE  -                            LE-   
Anterior segment:                                                                                             
Normal       
 Abnormal                      If yes mention condition : 
Posterior segment: 
Normal       DR 
 
 
 
 
 
DR: 
RE                                LE            
Grade of DR [RE]: 
Mild  / Moderate                          Severe                             PDR 
CSME :  Present   Absent   
Grade of DR [LE]: 
Mild  / Moderate                          Severe                             PDR 
CSME :  Present   Absent   
Fundus Photography:  RE  LE 
 
Choroidal thickness: 
 
  
Area RE LE 
 
Sub foveal 
  
 
Nasal 
  
 
Temporal 
  
 
 
ABBREVIATIONS 
 
DR    – Diabetic retinopathy 
CT    – Choroidal thickness 
NPDR   –  Non proliferative Diabetic retinopathy 
PDR    –  Proliferative diabetic retinopathy 
CSME   – Clinically significant macular oedema 
DME    – Diabetic macular oedema 
Ch BF  – Choroidal blood flow  
EDI –OCT  – Enhanced depth imaging optical coherence  
tomography 
RPE   – Retinal pigment epithelium 
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1 4037762 sulochana 58 f 211 5yrs On oral tab Nil Nil Nil Nil Nil 6/6 6/6 Normal normal Present Present Mod Mod Nil Nil 299 289 251 279 293 269
2 4041175 joy oonnommy 54 M 345 8 yrs On oral tab nil nil nil nil nil 4/60 6/18 Noral normal present presnet PDR severe nil present 293 279 227 248 242 286
3 4026899 HakkimE 58 M 170 12yrs oral tab nil nil nil nil nil 6/6 6/6 Normal normal Present Present Mild Mild nil nil 231 255 213 244 221 227
4 4028487 Muruganantham 57 M 337 5yrs on oral tab nil nil nil nil nil 6/6p 6/6p Normal Normal Predent Present Mod Mod nil nil 265 263 228 220 238 240
5 2866291 Chandra 50 F 115 10yrs on oral tab nil nil nil nil nil 6/12 6/9  Nuclear cat 2 Nuclear catract 1 present present mild mild nil nil 200 234 196 169 196 162
6 3800971 Arumugam Ravindran 49 M 350 13yrs oral tab nil nil nil nil nil 6/9 6/6 Normal normal Present present Mild Mild nil nil 265 272 204 241 210 231
7 4037325 chandrasekaran 58 M 123 15 days oral tab nil nil nil nil nil 6/12 6/9 Normal normal Present Presevt Mod severe nil present 234 272 189 241 214 244
8 4062489 Sebastien 53 M 193 8ys Insulin nil nil nil nil nil 6/12 6/18 Normal Normal Present Present Mod Mod nil nil 232 240 215 211 227 224
9 4010367 Sekaran 65 M 101 10yrs oral tab nil nil nil nil nil 6/18 6/12 Nuclear catract Nuclear catarct1 Present present Mod mod present present 320 295 265 249 280 270
10 4050786 gopal 49 M 168 10 months oral tab nil nil nil nil nil 6/18 6/12 Lens changes Lens changes Present present Mod Mod nil nil 279 280 265 265 255 270
11 4035342 Seran 59 M 144 4 yrs oral tab nil nil nil nil nil 6/12 6/12 Nuclear catract 1 Nuclear cataract 2 Present Present Mod Mod nil nil 248 232 217 207 240 235
12 3791297 Karuppaiah 52 M 135 3yrs oral tab nil nil nil nil nil 6/24 6/9 Lens changes Lens changes present present Sevre Mod present nil 285 279 228 212 255 260
13 1692478 chenniappan 60 M 120 2ys oral tab nil nil nil nil nil 6/9 6/6 Lens changes Lens changes present present mild mod nil nil 238 246 221 230 228 229
14 4112132 parameswari 52 F 148 5 months oral tab nil nil nil nil nil 6/12 6/9 Lens changes Lens changes present present mod mod nil nil 251 286 231 231 227 258
15 4112730 mareeswaran 58 M 132 6yrs oral tab nil nil nil nil nil 6/36 6/12 nuc catract 2 nuc catract 1 present present mod PDR presnt nil 273 317 259 287 262 303
16 411345 liyakath Ali 50 M 375 7yrs oral tab nil nil nil nil nil 6/60 6/60 Lens changes Lens changes present present PDR PDR nil nil 344 298 324 283 324 269
17 4114386 Posa Ragurammaiah 62 M 146 2yrs oral tab nil nil nil nil nil 6/12 6/6 Lens changes Lens changes present present mild mild nil nil 235 248 204 234 210 245
18 3099245 Mohan 55 M 216 10yrs oral tab nil nil nil nil nil 6/18 6/6 nuclear cat 1 nuc catract 1 present present mod mild nil nil 248 220 234 204 245 203
19 3022755 Krishnakumari 62 F 230 12yrs oral tab nil nil nil nil nil 6/9 6/36 Lens changes Lens changes present present mod mod present present 268 257 216 215 238 229
20 3037553 selvi 55 F 186 13 yrs oral tab nil nil nil nil nil 6/6 6/6 clear clear present present Mild mod nil nil 230 218 216 218 230 229
21 2815439 Ahmed 61 M 187 10yrs oral tab nil nil nil nil nil 6/9 6/9 lenschanges Lens changes present present mod mod nil nil 200 198 189 191 192 194
MASTER CHART - DIABETIC RETINOPATHY 
S.NO MR NO Name Age Sex Subfoveal RE Subfoveal LE Nasal RE Nasal LE Temporal RE Temporal LE
1 1976238 PREMALATHA 50 F 280 249 258
2 840830 GANESAN 45 M 406.5 383 378.5 341 225 288
3 1976231 DHANBAK 53 F 336.5 274 265.5 237.5 282 227
4 1683059 PALANISAMY 47 M 243.5 237.5 232 164 218.5 229
5 1977982 rengaraj 44 M 287.5 233 188
6 1977917 SHABEER ALI 34 M 431.5 422.5 375.5 397 380.5 194.5
7 1977943 CHANDRASEKAR 44 M 377 292 317.5 292.5 344 269.5
8 1977927 RAJAGOPALAN 61 M 249 242 173 193 147.5 176.5
9 1977919 SARASWATHI 52 F 338 229 282 404 262 221.5
10 1978719 CHANDRASEKAR S 43 M 237.5 274 147 206 218.5 208.5
11 1436019 LOGAMBAL 41 F 333 459.5 328 396.5 383 397.5
12 1980374 S BABY 40 F 270.5 290 237.5 228 333 246
13 1980340 KANAMMAL 48 F 326.5 259.5 306 275.5 240 194.5
14 1980342 SHANMUGAM 67 M 293.5 271.5 287 247.5 272 176.5
15 1980359 CHINNAPONNU 45 F 276.5 280 178 272 179 199.5
16 1981179 chandrika 60 F 281.5 236 300 280 291.5 224
17 1981192 AMUTHA 48 F 354 349.5 315 299.5 272.5 302.5
18 1981219 REJINI 40 F 396.5 421.5 298.5 343 267 343.5
19 1981520 SRINIVASAN 50 M 302.5 236.5 252.5
20 1984402 NALINI 52 F 352 282 275.5 229 348 285
21 1759415 S K SUDHA 33 F 359 330.5 317 346.5 346.5 297
22 1981594  BALAKRISHNAN 42 M 239.5 230.5 168 208 216 174
23 1984391 SAIDALI 59 M 324.5 219 231.5 214 233.5 147
24 1984424 NALLASAMY 40 M 207 196 157.5
25 1984413 NIRMALADEVI 43 F 357 476.5 232.5 456.5 324.5 432
MASTER CHART - NORMAL DATA
 
 
 
  
 
 
 
  
 
 
